MOLECULAR ANALYSIS OF A COMPLETE HIV-1 Pol GENE ISOLATED IN CENTRAL JAVA, INDONESIA
Background: HIV-1 is an infectious agent causing global health problem. Molecular analysis of HIV-1 strains is crucial due to the association with viral fitness, drug resistance, serological failure, and more importantly, for vaccine development. However, HIV-1 molecular data in Indonesia is limited, including that of the HIV pol gene. Aims: The present study performed a molecular analysis of the pol gene of HIV isolated in Central Java, Indonesia, in order to enrich HIV-1 molecular data in Indonesia, particularly in Central Java.Methods: A complete coding sequence of pol gene was cloned from 09IDSKA-6 (HIV isolated in Central Java, Indonesia), inserted into an Escherichia coli expression plasmid, and sequenced. The sequencing results of the pol gene then subjected for virus subtyping, genotyping, and phylogenetic analysis. The drug resistance, identification of the HLA binding motifs and viral epitopes, proteomic motifs, and physicochemical analysis was performed.Results: The HIV-1 isolate analyzed in this study was CRF01_AE strain. The isolate remains in low evolutionary state due to the low level of nonsynonymous to synonymous substitutions ratio (dN/dS). None of mutations identified was related to ARV drug resistance. A total of 33 CTL/CD8+ epitopes, 6 T-helper/CD4+ epitopes and 2 antibody epitopes were identified in our isolate. Six distinct proteomic domains were found. Physicochemical analysis revealed the molecular weight (Mw), estimated half-life, instability index, aliphatic index, and hydrophilicity of each proteins encoded by the complete HIV-1 pol gene.
Keywords: HIV-1, pol gene, Indonesia.
Baxter, J.D., J.M. Schapiro,C.A.B. Boucher, V.M. Kohlbrenner, D.B. Hall, J.R. Scherer, and D.L. Mayers. 2006. Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. J Virol, vol. 80:10794-10801.
Bruzzone, B., A. Ventura, F. Bisio, F.A. Mboungou, L.M. Miguel, F. Saladini, M. Zazzi, G. Icardi, A. De Maria, and C. Viscoli C. 2010. Impact of extensive HIV-1 variability on molecular diagnosis in the Congo basin.J ClinVirol, vol. 47:372-375.
Chen, C.P., and B. Rost. 2002. State-of-the-art in membrane protein prediction.Appl Bioinformatics, vol. 1:21-35.
Gordon, M., T. De Oliveira, K. Bishop, H.M. Coovadia, L. Madurai, S. Engelbrecht, E. Janse van Rensburg, A. Mosam, A. Smith, and S. Cassol. 2003. Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies. J Virol, vol. 77:2587- 2599.
Hopp, T.P., and K.R. Woods. 1981. Prediction of protein antigenic determinants from amino acid sequences. ProcNatlAcadSci USA, vol.78:3824-3828.
Hughes, A.L., J.A. Green, J.M. Garbayo, and R.M. Roberts. 2000. Adaptive diversification within a large family of recently duplicated, placentally expressed genes.ProcNatlAcadSci USA, vol. 97:3319-3323.
Kemal, K.S., M. Reinis, B. Weiser, and H. Burger. 2009.Methods for Viral RNA Isolation and PCR Amplificationfor Sequencing of Near Full-Length HIV-1 Genomes. In: HIV Protocols. Humana Press. New York.
Kiwanuka, N., M. Robb, O. Laeyendecker, G. Kigozi, F. Wabwire-Mangen, F.E. Makumbi, F. Nalugoda, J. Kagaayi, M. Eller, L.A. Eller, D. Serwadda, N.K. Sewankambo, S.J. Reynolds, T.C. Quinn, R.H. Gray, M.J. Wawer, and C.C. Whalen. 2010. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune DeficSyndr, vol. 54:180-184.
Merati, T.P., R.E. Ryan, T. Spelmen, D.N. Wirawan, I.M. Bakta, B. Otto, R.B. Oelrichs, and S.M. Crowe. 2012. CRF01_AE dominates the HIV-1 epidemic in Indonesia. Sex Health,vol. 9:414-421.
Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions.MolBiolEvol, vol. 3:418-426.
Sahbandar, I.N., K. Takahashi, Z. Djoerban, I. Firmansyah, S. Naganawa, K. Motomura, H. Sato, K. Kitamura, H.T. Pohan, and S. Sato. 2009. Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia.AIDS Res Hum Retroviruses,vol. 25:637-646.
Sire, J.M., M. Vray, M. Merzouk, J.C. Plantier, J. Pavie, S. Maylin, J. Timsit, C. Lascoux- Combe, J.M. Molina, F. Simon, and C. Delaugerre. 2011. Comparative RNA quantification of HIV-1 group M and non-M with the RoscheCobasAmpliPrep/Cobas TaqManHIV-1 v2/ 0 and Abbortt Real-Time HIV-1 PCR assays. J Acquir Immune DeficSyndr, vol. 56:239- 243.
Tamura, K., D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar. 2011. MEGA5: molecular evolutionary genetic analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol,vol. 28:2731-2739.
Wayengera, M. 2011. Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapy.TheorBiol Med Model, vol. 8:26.
Xia, X., W.H. Li. 1998. What amino acid properties affect protein evolution?JMolEvol, vol. 47:557-564.